(ATAT) Atour Lifestyle Holdings - Overview
Exchange: NASDAQ •
Country: China •
Currency: USD •
Type: Common Stock •
ISIN: US04965M1062
Stock: Hotels, Retail, Travel, Management, Supplies
Total Rating 57
Risk 79
Buy Signal -0.99
| Risk 5d forecast | |
|---|---|
| Volatility | 43.0% |
| Relative Tail Risk | -4.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.65 |
| Alpha | 4.60 |
| Character TTM | |
|---|---|
| Beta | 1.113 |
| Beta Downside | 1.859 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.45% |
| CAGR/Max DD | 0.44 |
EPS (Earnings per Share)
Revenue
Description: ATAT Atour Lifestyle Holdings February 25, 2026
Atour Lifestyle Holdings Limited (NASDAQ: ATAT) is a Shanghai-based company that develops and manages lifestyle-oriented hotel brands across mainland China. Through its subsidiaries, it delivers a suite of services that includes hotel and retail management, investment and financial information services, property management, technology solutions, and operates a travel agency for franchise partners.
Recent performance indicators show the firm benefitting from China’s post-pandemic tourism rebound: FY 2023 revenue rose ~12% YoY to approximately $45 million, while average hotel occupancy for its managed properties reached 68% in Q4 2023, up from 60% a year earlier. The broader Chinese hotel sector is projected to grow at a 5% CAGR through 2028, driven by rising domestic travel spending, which increased 9% YoY in Q1 2024, and supportive government policies encouraging “stay-cation” tourism.
For a deeper dive into ATAT’s valuation metrics and peer comparison, you might explore ValueRay’s research tools.
Headlines to watch out for
- Hotel occupancy rates in China
- Franchise expansion and new hotel openings
- Retail sales of hotel-branded merchandise
- Chinese tourism policy and travel restrictions
- Competition from other hospitality brands
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.62b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA -0.56 > 1.0 |
| NWC/Revenue: 37.20% < 20% (prev 39.75%; Δ -2.56% < -1%) |
| CFO/TA 0.22 > 3% & CFO 1.98b > Net Income 1.62b |
| Net Debt (-1.78b) to EBITDA (2.27b): -0.78 < 3 |
| Current Ratio: 1.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (139.5m) vs 12m ago -0.18% < -2% |
| Gross Margin: 44.07% > 18% (prev 0.42%; Δ 4.37k% > 0.5%) |
| Asset Turnover: 114.5% > 50% (prev 92.13%; Δ 22.40% > 0%) |
| Interest Coverage Ratio: 526.2 > 6 (EBITDA TTM 2.27b / Interest Expense TTM 4.22m) |
Altman Z'' 5.53
| A: 0.40 (Total Current Assets 7.36b - Total Current Liabilities 3.73b) / Total Assets 9.17b |
| B: 0.24 (Retained Earnings 2.20b / Total Assets 9.17b) |
| C: 0.26 (EBIT TTM 2.22b / Avg Total Assets 8.53b) |
| D: 0.39 (Book Value of Equity 2.16b / Total Liabilities 5.59b) |
| Altman-Z'' Score: 5.53 = AAA |
Beneish M -2.75
| DSRI: 1.20 (Receivables 534.1m/332.2m, Revenue 9.76b/7.26b) |
| GMI: 0.95 (GM 44.07% / 41.78%) |
| AQI: 0.92 (AQ_t 0.05 / AQ_t-1 0.06) |
| SGI: 1.35 (Revenue 9.76b / 7.26b) |
| TATA: -0.04 (NI 1.62b - CFO 1.98b) / TA 9.17b) |
| Beneish M-Score: -2.75 (Cap -4..+1) = A |
What is the price of ATAT shares?
As of March 22, 2026, the stock is trading at USD 36.88 with a total of 1,652,608 shares traded.
Over the past week, the price has changed by +4.65%, over one month by -5.34%, over three months by -13.31% and over the past year by +24.79%.
Over the past week, the price has changed by +4.65%, over one month by -5.34%, over three months by -13.31% and over the past year by +24.79%.
Is ATAT a buy, sell or hold?
Atour Lifestyle Holdings has received a consensus analysts rating of 4.80.
Therefore, it is recommended to buy ATAT.
- StrongBuy: 12
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ATAT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 49.6 | 34.5% |
| Analysts Target Price | 49.6 | 34.5% |
ATAT Fundamental Data Overview March 21, 2026
P/E Trailing = 24.8235
P/E Forward = 20.0401
P/S = 0.5361
P/B = 9.4809
Revenue TTM = 9.76b USD
EBIT TTM = 2.22b USD
EBITDA TTM = 2.27b USD
Long Term Debt = 2.00m USD (from longTermDebt, two quarters ago)
Short Term Debt = 480.5m USD (from shortTermDebt, last quarter)
Debt = 1.53b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.78b USD (from netDebt column, last quarter)
Enterprise Value = 903.8m USD (5.25b + Debt 1.53b - CCE 5.87b)
Interest Coverage Ratio = 526.2 (Ebit TTM 2.22b / Interest Expense TTM 4.22m)
EV/FCF = 0.48x (Enterprise Value 903.8m / FCF TTM 1.89b)
FCF Yield = 209.5% (FCF TTM 1.89b / Enterprise Value 903.8m)
FCF Margin = 19.39% (FCF TTM 1.89b / Revenue TTM 9.76b)
Net Margin = 16.56% (Net Income TTM 1.62b / Revenue TTM 9.76b)
Gross Margin = 44.07% ((Revenue TTM 9.76b - Cost of Revenue TTM 5.46b) / Revenue TTM)
Gross Margin QoQ = 43.96% (prev 43.61%)
Tobins Q-Ratio = 0.10 (Enterprise Value 903.8m / Total Assets 9.17b)
Interest Expense / Debt = 0.15% (Interest Expense 2.34m / Debt 1.53b)
Taxrate = 30.94% (211.4m / 683.2m)
NOPAT = 1.53b (EBIT 2.22b * (1 - 30.94%))
Current Ratio = 1.97 (Total Current Assets 7.36b / Total Current Liabilities 3.73b)
Debt / Equity = 0.42 (Debt 1.53b / totalStockholderEquity, last quarter 3.60b)
Debt / EBITDA = -0.78 (Net Debt -1.78b / EBITDA 2.27b)
Debt / FCF = -0.94 (Net Debt -1.78b / FCF TTM 1.89b)
Total Stockholder Equity = 3.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.97% (Net Income 1.62b / Total Assets 9.17b)
RoE = 46.59% (Net Income TTM 1.62b / Total Stockholder Equity 3.47b)
RoCE = 63.88% (EBIT 2.22b / Capital Employed (Equity 3.47b + L.T.Debt 2.00m))
RoIC = 43.80% (NOPAT 1.53b / Invested Capital 3.50b)
WACC = 7.79% (E(5.25b)/V(6.77b) * Re(10.02%) + D(1.53b)/V(6.77b) * Rd(0.15%) * (1-Tc(0.31)))
Discount Rate = 10.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.29%
[DCF] Terminal Value 81.70% ; FCFF base≈1.80b ; Y1≈2.18b ; Y5≈3.55b
[DCF] Fair Price = 569.5 (EV 62.93b - Net Debt -1.78b = Equity 64.71b / Shares 113.6m; r=7.79% [WACC]; 5y FCF grow 22.40% → 2.90% )
EPS Correlation: 67.60 | EPS CAGR: 98.70% | SUE: 0.21 | # QB: 0
Revenue Correlation: 96.23 | Revenue CAGR: 61.81% | SUE: -0.18 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.98 | Chg7d=-0.283 | Chg30d=-0.283 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=14.45 | Chg7d=-0.424 | Chg30d=-0.437 | Revisions Net=+1 | Growth EPS=+15.3% | Growth Revenue=+23.8%
EPS next Year (2027-12-31): EPS=17.81 | Chg7d=-0.513 | Chg30d=-0.502 | Revisions Net=-1 | Growth EPS=+23.2% | Growth Revenue=+19.4%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 6.0% (Discount Rate 10.0% - Earnings Yield 4.0%)
[Growth] Growth Spread = +16.3% (Analyst 22.3% - Implied 6.0%)
P/E Forward = 20.0401
P/S = 0.5361
P/B = 9.4809
Revenue TTM = 9.76b USD
EBIT TTM = 2.22b USD
EBITDA TTM = 2.27b USD
Long Term Debt = 2.00m USD (from longTermDebt, two quarters ago)
Short Term Debt = 480.5m USD (from shortTermDebt, last quarter)
Debt = 1.53b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.78b USD (from netDebt column, last quarter)
Enterprise Value = 903.8m USD (5.25b + Debt 1.53b - CCE 5.87b)
Interest Coverage Ratio = 526.2 (Ebit TTM 2.22b / Interest Expense TTM 4.22m)
EV/FCF = 0.48x (Enterprise Value 903.8m / FCF TTM 1.89b)
FCF Yield = 209.5% (FCF TTM 1.89b / Enterprise Value 903.8m)
FCF Margin = 19.39% (FCF TTM 1.89b / Revenue TTM 9.76b)
Net Margin = 16.56% (Net Income TTM 1.62b / Revenue TTM 9.76b)
Gross Margin = 44.07% ((Revenue TTM 9.76b - Cost of Revenue TTM 5.46b) / Revenue TTM)
Gross Margin QoQ = 43.96% (prev 43.61%)
Tobins Q-Ratio = 0.10 (Enterprise Value 903.8m / Total Assets 9.17b)
Interest Expense / Debt = 0.15% (Interest Expense 2.34m / Debt 1.53b)
Taxrate = 30.94% (211.4m / 683.2m)
NOPAT = 1.53b (EBIT 2.22b * (1 - 30.94%))
Current Ratio = 1.97 (Total Current Assets 7.36b / Total Current Liabilities 3.73b)
Debt / Equity = 0.42 (Debt 1.53b / totalStockholderEquity, last quarter 3.60b)
Debt / EBITDA = -0.78 (Net Debt -1.78b / EBITDA 2.27b)
Debt / FCF = -0.94 (Net Debt -1.78b / FCF TTM 1.89b)
Total Stockholder Equity = 3.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.97% (Net Income 1.62b / Total Assets 9.17b)
RoE = 46.59% (Net Income TTM 1.62b / Total Stockholder Equity 3.47b)
RoCE = 63.88% (EBIT 2.22b / Capital Employed (Equity 3.47b + L.T.Debt 2.00m))
RoIC = 43.80% (NOPAT 1.53b / Invested Capital 3.50b)
WACC = 7.79% (E(5.25b)/V(6.77b) * Re(10.02%) + D(1.53b)/V(6.77b) * Rd(0.15%) * (1-Tc(0.31)))
Discount Rate = 10.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.29%
[DCF] Terminal Value 81.70% ; FCFF base≈1.80b ; Y1≈2.18b ; Y5≈3.55b
[DCF] Fair Price = 569.5 (EV 62.93b - Net Debt -1.78b = Equity 64.71b / Shares 113.6m; r=7.79% [WACC]; 5y FCF grow 22.40% → 2.90% )
EPS Correlation: 67.60 | EPS CAGR: 98.70% | SUE: 0.21 | # QB: 0
Revenue Correlation: 96.23 | Revenue CAGR: 61.81% | SUE: -0.18 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.98 | Chg7d=-0.283 | Chg30d=-0.283 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=14.45 | Chg7d=-0.424 | Chg30d=-0.437 | Revisions Net=+1 | Growth EPS=+15.3% | Growth Revenue=+23.8%
EPS next Year (2027-12-31): EPS=17.81 | Chg7d=-0.513 | Chg30d=-0.502 | Revisions Net=-1 | Growth EPS=+23.2% | Growth Revenue=+19.4%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 6.0% (Discount Rate 10.0% - Earnings Yield 4.0%)
[Growth] Growth Spread = +16.3% (Analyst 22.3% - Implied 6.0%)